Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term oxycodone exposure produces delayed and persistent gut microbiome disruption in mice.

bioRxiv : the preprint server for biology·2026
Same author

Impact of acromegaly subtypes on survival: results from a large multicenter cohort.

Journal of the Endocrine Society·2026
Same author

Feasibility of longitudinal relaxation rate mapping with non-Cartesian sampling and compressed sensing on a 1.5 T magnetic resonance linear accelerator.

Physics and imaging in radiation oncology·2026
Same author

Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials.

European urology·2026
Same author

A single-cell multiomic analysis identifies molecular and gene-regulatory mechanisms dysregulated in developing Down syndrome neocortex.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Mar 25, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

NSCLC tumor shrinkage prediction using quantitative image features.

Luke A Hunter1, Yi Pei Chen1, Lifei Zhang1

  • 1Department of Radiation Physics, The University of Texas, MD Anderson Cancer Centre, 1515 Holcombe, Houston, TX 77030, USA.

Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|February 16, 2016
PubMed
Summary
This summary is machine-generated.

This study developed a quantitative image model to predict non-small cell lung cancer (NSCLC) volume shrinkage using pre-treatment CT scans. The model accurately predicts tumor shrinkage, aiding clinical decisions for NSCLC patients.

Keywords:
NSCLCQuantitative image featurepredictiontexturetumor shrinkage

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.7K

Related Experiment Videos

Last Updated: Mar 25, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.7K

Area of Science:

  • Radiology
  • Medical Imaging
  • Oncology

Background:

  • Non-small cell lung cancer (NSCLC) treatment response varies significantly among patients.
  • Accurate prediction of tumor shrinkage is crucial for personalized treatment strategies and prognosis.
  • Current methods for assessing tumor response often rely on delayed measurements.

Purpose of the Study:

  • To develop and validate a quantitative image feature model for predicting NSCLC volume shrinkage.
  • To utilize pre-treatment computed tomography (CT) images for early prediction of treatment response.
  • To assess the model's performance against traditional population-based shrinkage predictions.

Main Methods:

  • Extracted quantitative image features (geometric, histogram, gradient, co-occurrence, run-length) from pre-treatment CT scans of 64 NSCLC patients.
  • Developed prediction models using principal component regression and simulated annealing subset selection.
  • Quantified tumor shrinkage by comparing planning gross tumor volume (GTV) to week 6 treatment GTV, validated using permutation tests.

Main Results:

  • The optimal prediction model achieved a strong correlation (r=0.81) between observed and predicted tumor shrinkage.
  • The model demonstrated a mean squared error (MSE) of 8.60×10(-3).
  • The developed model reduced MSE by 2.92-fold compared to predictions based on mean population shrinkage.

Conclusions:

  • Quantitative image features from pre-treatment CT scans can effectively predict NSCLC tumor shrinkage.
  • This predictive model offers valuable insights for clinical decision-making, including risk stratification and prognosis.
  • The findings support the integration of quantitative imaging biomarkers into routine NSCLC patient management.